Literature DB >> 23127146

Is polycystic ovary syndrome, a state of relative estrogen excess, a real risk factor for estrogen-dependant malignancies?

Michael Fanta1.   

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrinopathy affecting women of fertile age. It is associated with several risk factors and long-term health consequences. Chronic anovulation combined with relative estrogen excess and consequent prolonged stimulatory effect on the endometrium can lead to the pathogenesis of hormonal dependant carcinoma. PCOS is thus traditionally reported to be associated with increased risk of endometrial, as well as breast and ovarian cancers. This article provides a critical literature review of the relationship between PCOS and the incidence of estrogen-dependant gynecological tumours, and it then discusses whether the commonly cited risk factor association can be substantiated by high quality studies which comply with the requirements of "evidence-based medicine."

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23127146     DOI: 10.3109/09513590.2012.730575

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  3 in total

1.  Assessment of GSTO1 (A140D) and GSTO2 (N142D) Gene Polymorphisms in Iranian Women with Polycystic Ovarian Syndrome.

Authors:  Seyyed Shahram Miraghaee; Maryam Sohrabi; Cyrus Jalili; Fariborz Bahrehmand
Journal:  Rep Biochem Mol Biol       Date:  2020-04

2.  MicroRNA-132 promotes estradiol synthesis in ovarian granulosa cells via translational repression of Nurr1.

Authors:  Shaogen Wu; Haixiang Sun; Qun Zhang; Yue Jiang; Ting Fang; Isabelle Cui; Guijun Yan; Yali Hu
Journal:  Reprod Biol Endocrinol       Date:  2015-08-19       Impact factor: 5.211

3.  Predictive modes of action of pesticides in uterine adenocarcinoma development in rats.

Authors:  Midori Yoshida; Kaoru Inoue; Miwa Takahashi
Journal:  J Toxicol Pathol       Date:  2015-08-27       Impact factor: 1.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.